Literature DB >> 20560610

A human single chain transbody specific to matrix protein (M1) interferes with the replication of influenza A virus.

Ornnuthchar Poungpair1, Anek Pootong, Santi Maneewatch, Potjanee Srimanote, Pongsri Tongtawe, Thaweesak Songserm, Pramuan Tapchaisri, Wanpen Chaicumpa.   

Abstract

A cell penetrating format of human single chain antibody (HuScFv) specific to matrix protein (M1) of influenza A virus was produced by molecular linking of the gene sequence encoding the HuScFv (huscfv) to a protein transduction domain, i.e., penetratin (PEN) of the Drosophila homeodomain. DNA of a recombinant phagemid vector carrying the huscfv was used as a platform template in a three-step PCR for generating a nucleotide sequence encoding a 16 amino acid PEN peptide. The PEN-HuScFv had negligible cytotoxicity on living MDCK cells. They were readily translocated across the cell membrane and bound to native M1 in the A/H5N1-infected cells as revealed by immunofluorescent confocal microscopy. The PEN-HuScFv, when used to treat the influenza virus infected cells, reduced the number of viruses released from the cells. In conclusion, the cell penetrating M1-specific HuScFv, a transbody, produced in this study affected the influenza A virus life cycle in living mammalian cells. While the molecular mechanisms of the PEN-HuScFv need more investigation, the reagent warrants further testing in animals before developing it into a human immunotherapeutic anti-influenza formula.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20560610     DOI: 10.1021/bc900251u

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  19 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Endosomal escape efficiency of fusogenic B18 and B55 peptides fused with anti-EGFR single chain Fv as estimated by nuclear translocation.

Authors:  Keisuke Niikura; Kenichi Horisawa; Nobuhide Doi
Journal:  J Biochem       Date:  2015-09-02       Impact factor: 3.387

Review 3.  Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

4.  Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.

Authors:  Yiping Li; Zhengwen Liu; Lingyun Hui; Xi Liu; Ai Feng; Wei Wang; Lin Zhang; Na Li; Guoqing Zhou; Quanli Wang; Qunying Han; Yi Lv; Quanying Wang; Guangxiao Yang; Yawen Wang
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

5.  Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle.

Authors:  Ornnuthchar Poungpair; Kunan Bangphoomi; Prapaipit Chaowalit; Nunghathai Sawasdee; Nichapatr Saokaew; Kiattawee Choowongkomon; Wanpen Chaicumpa; Pa-thai Yenchitsomanus
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

6.  Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.

Authors:  Kanyarat Thueng-in; Jeeraphong Thanongsaksrikul; Surasak Jittavisutthikul; Watee Seesuay; Monrat Chulanetra; Yuwaporn Sakolvaree; Potjanee Srimanote; Wanpen Chaicumpa
Journal:  MAbs       Date:  2014       Impact factor: 5.857

7.  Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.

Authors:  Kanyarat Thueng-in; Jeeraphong Thanongsaksrikul; Potjanee Srimanote; Kunan Bangphoomi; Ornnuthchar Poungpair; Santi Maneewatch; Kiattawee Choowongkomon; Wanpen Chaicumpa
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

Review 8.  Botulinum neurotoxins and botulism: a novel therapeutic approach.

Authors:  Jeeraphong Thanongsaksrikul; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2011-05-13       Impact factor: 4.546

9.  Humanized-VHH transbodies that inhibit HCV protease and replication.

Authors:  Surasak Jittavisutthikul; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-In; Monrat Chulanetra; Potjanee Srimanote; Watee Seesuay; Aijaz Ahmad Malik; Wanpen Chaicumpa
Journal:  Viruses       Date:  2015-04-20       Impact factor: 5.048

10.  Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity.

Authors:  Charnwit Chavanayarn; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-In; Kunan Bangphoomi; Nitat Sookrung; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2012-07-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.